These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 13679716)

  • 1. [Chemotherapeutic neurotoxicity].
    Lebrun C; Frenay M
    Rev Neurol (Paris); 2003 Sep; 159(8-9):741-54. PubMed ID: 13679716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurologic side effects of cytotoxic drugs].
    Lebrun C; Frenay M
    Rev Med Interne; 2010 Apr; 31(4):295-304. PubMed ID: 20167398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
    Nakane M
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurologic complications of chemotherapy].
    Lebrun C; Frenay M; Lanteri-Minet M
    Rev Med Interne; 1999 Oct; 20(10):902-11. PubMed ID: 10573726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced peripheral neuropathy.
    Hilkens PH; ven den Bent MJ
    J Peripher Nerv Syst; 1997; 2(4):350-61. PubMed ID: 10975744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurotoxicity with cytostatic therapy: a review].
    Cerny T; Meier C
    Schweiz Med Wochenschr; 1989 Aug; 119(34):1137-47. PubMed ID: 2554491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity of cancer chemotherapy.
    Dropcho EJ
    Semin Neurol; 2010 Jul; 30(3):273-86. PubMed ID: 20577934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological damage of brain tumor therapy].
    Ricard D; De Greslan T; Soussain C; Bounolleau P; Sallansonnet-Froment M; Delmas JM; Taillia H; Martin-Duverneuil N; Renard JL; Hoang-Xuan K
    Rev Neurol (Paris); 2008; 164(6-7):575-87. PubMed ID: 18565357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic complications of cancer chemotherapy.
    Sul JK; Deangelis LM
    Semin Oncol; 2006 Jun; 33(3):324-32. PubMed ID: 16769421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
    Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
    Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral nervous system toxicity of common chemotherapeutic agents.
    Sioka C; Kyritsis AP
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):761-7. PubMed ID: 19034447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic complications of cancer drug therapies.
    Lee EQ; Arrillaga-Romany IC; Wen PY
    Continuum (Minneap Minn); 2012 Apr; 18(2):355-65. PubMed ID: 22810132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic complications of chemotherapy.
    Macdonald DR
    Neurol Clin; 1991 Nov; 9(4):955-67. PubMed ID: 1758434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy induced neurotoxicity].
    Shimoyama N; Takahashi H; Yamamoto N; Simoyama M
    Nihon Rinsho; 2003 Jun; 61(6):995-1000. PubMed ID: 12806949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
    Cavaletti G; Frigeni B; Lanzani F; Mattavelli L; Susani E; Alberti P; Cortinovis D; Bidoli P
    Eur J Cancer; 2010 Feb; 46(3):479-94. PubMed ID: 20045310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity.
    Marmiroli P; Nicolini G; Miloso M; Scuteri A; Cavaletti G
    Ital J Anat Embryol; 2012; 117(2):75-97. PubMed ID: 23420996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
    Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
    Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system toxicity from cancer therapies.
    Schiff D; Wen P
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1377-98. PubMed ID: 17113469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Plasmati R; Cangini D; Tacchetti P; Perrone G; Pastorelli F; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2005 Mar; 74(3):212-6. PubMed ID: 15693790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.